90 results
Page 4 of 5
8-K
EX-4.1
y0jgsi2n7h5b
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-4.2
92qxbyve0i
6 Apr 10
Additional proxy soliciting materials
12:00am
8-K
EX-4.3
acv ppb9mh54sm3u5yr
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.2
f1d3dtdksx22n
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-4.3
7upjlh9oyy3eqdodau
6 Apr 10
Additional proxy soliciting materials
12:00am
DEFA14A
EX-4.1
eq3v6xmbcpz5xa y95z
6 Apr 10
Additional proxy soliciting materials
12:00am
8-K
EX-4.1
aklrhq31rnj
5 Mar 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
1yy3r
14 Jan 10
MDRNA, Inc. Raises $5.5 Million in Registered Direct Offering
12:00am
8-K
EX-4.2
55ppa2sfh30
24 Dec 09
MDRNA, Inc. Announces Closing of $1 Million Bridge Loan
12:00am
8-K
EX-4.1
u865 3gqkh
24 Dec 09
MDRNA, Inc. Announces Closing of $1 Million Bridge Loan
12:00am
8-K
EX-4.1
r4g34le1f2vchy t2
19 Jan 07
Entry into a Material Definitive Agreement
12:00am
S-8
EX-4.5
zqfkawig0zi4
10 Jul 02
Registration of securities for employees
12:00am
8-K
EX-4.1
ttzrusicec
20 Feb 02
Nastech and Pharmacia Reach Worldwide Agreement to Develop and Market Nasally Administered Apomorphine
12:00am
8-K
EX-4.2
13zyl jdh8gaqz89p9
20 Feb 02
Nastech and Pharmacia Reach Worldwide Agreement to Develop and Market Nasally Administered Apomorphine
12:00am